176 related articles for article (PubMed ID: 2031975)
1. Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies: a potentiating role for amsacrine.
Vlasveld LT; Zwaan FE; Fibbe WE; Tjon RT; Tham TA; Kluin PM; Willemze R
Ann Hematol; 1991 Apr; 62(4):129-34. PubMed ID: 2031975
[TBL] [Abstract][Full Text] [Related]
2. Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography.
Cartoni C; Dragoni F; Micozzi A; Pescarmona E; Mecarocci S; Chirletti P; Petti MC; Meloni G; Mandelli F
J Clin Oncol; 2001 Feb; 19(3):756-61. PubMed ID: 11157028
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary complications of cytosine-arabinoside therapy: radiographic findings.
Tham RT; Peters WG; de Bruïne FT; Willemze R
AJR Am J Roentgenol; 1987 Jul; 149(1):23-7. PubMed ID: 3495987
[TBL] [Abstract][Full Text] [Related]
4. [Neutropenic typhlitis: a frequently missed complication of aplasia-inducing tumor therapy with a possible association to the combination of etoposide with high-dose cytosine-arabinoside].
Benz G; Gmür J; Gubler J
Schweiz Med Wochenschr; 1994 Feb; 124(5):186-92. PubMed ID: 8128200
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and outcome of neutropenic enterocolitis: experience in a single tertiary pediatric surgical center in China.
Li K; Zheng S; Dong K; Gao Y; Wang H; Liu G; Gao J; Xiao X
Pediatr Surg Int; 2011 Nov; 27(11):1191-5. PubMed ID: 21667116
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results of consolidation therapy with high-dose cytosine arabinoside for patients with bad-risk or relapsed acute leukemia or lymphoblastic non-Hodgkin's lymphoma.
Peters WG; Willemze R; Colly LP
Eur J Cancer Clin Oncol; 1987 Apr; 23(4):401-5. PubMed ID: 3609104
[TBL] [Abstract][Full Text] [Related]
7. High-dose cytosine arabinoside and viridans streptococcus sepsis in children with leukemia.
Rossetti F; Cesaro S; Putti MC; Zanesco L
Pediatr Hematol Oncol; 1995; 12(4):387-92. PubMed ID: 7577391
[TBL] [Abstract][Full Text] [Related]
8. Neutropenic enterocolitis after high-dose chemotherapy and autologous stem cell transplantation: incidence, risk factors, and outcome.
Gil L; Poplawski D; Mol A; Nowicki A; Schneider A; Komarnicki M
Transpl Infect Dis; 2013 Feb; 15(1):1-7. PubMed ID: 22862907
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
Xie XT; Jiang SY; Li BS; Yang LL
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside.
Dhaliwal HS; Shannon MS; Barnett MJ; Prentice HG; Bragman K; Malpas JS; Lister TA
Cancer Chemother Pharmacol; 1986; 18(1):59-62. PubMed ID: 3463435
[TBL] [Abstract][Full Text] [Related]
11. Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.
Willemze R; Peters WG; van Hennik MB; Fibbe WE; Kootte AM; van Berkel M; Lie R; Rodenburg CJ; Veltkamp JJ
Scand J Haematol; 1985 Jan; 34(1):83-7. PubMed ID: 3855571
[TBL] [Abstract][Full Text] [Related]
12. Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia.
Camera A; Andretta C; Villa MR; Volpicelli M; Picardi M; Rossi M; Rinaldi CR; Della Cioppa P; Ciancia R; Selleri C; Rotoli B
Hematol J; 2003; 4(5):346-50. PubMed ID: 14502260
[TBL] [Abstract][Full Text] [Related]
13. Successful medical management of neutropenic enterocolitis (typhlitis) in a child with acute lymphoblastic leukemia.
Ozçay F; Kayiran SM; Ozbek N
Turk J Pediatr; 2003; 45(3):248-50. PubMed ID: 14696805
[TBL] [Abstract][Full Text] [Related]
14. Ara-C fever and infections after high-dose ara-C treatment in pediatric lymphoid malignancies.
Ek T; Pinkava M; Abrahamsson J
J Pediatr Hematol Oncol; 2005 Jul; 27(7):364-9. PubMed ID: 16012325
[TBL] [Abstract][Full Text] [Related]
15. High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma.
Rohatiner A; Slevin ML; Dhaliwal HS; Malpas JS; Lister TA
Cancer Chemother Pharmacol; 1984; 12(2):90-3. PubMed ID: 6697429
[TBL] [Abstract][Full Text] [Related]
16. Neutropenic enterocolitis in a patient with colorectal carcinoma: unusual course after treatment with 5-fluorouracil and leucovorin--a case report.
Kronawitter U; Kemeny NE; Blumgart L
Cancer; 1997 Aug; 80(4):656-60. PubMed ID: 9264347
[TBL] [Abstract][Full Text] [Related]
17. Neutropenic enterocolitis in adult leukemias.
Büyükaşik Y; Ozcebe OI; Haznedaroğlu IC; Sayinalp N; Soylu AR; Ozdemir O; Dündar S
Int J Hematol; 1997 Jul; 66(1):47-55. PubMed ID: 9220660
[TBL] [Abstract][Full Text] [Related]
18. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
Hansen OP; Pedersen-Bjergaard J; Ellegaard J; Brincker H; Boesen AM; Christensen BE; Drivsholm A; Hippe E; Jans H; Jensen KB
Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of a continuous infusion of high-dose ara-C in conjunction with a fixed dose of 2'-deoxycytidine (IND 28108) in patients with refractory leukemia: an interim report.
Grant S; Baker M; Bhalla K
Leukemia; 1993 Dec; 7(12):1933-8. PubMed ID: 8255091
[TBL] [Abstract][Full Text] [Related]
20. Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside.
Hogan WJ; Letendre L; Litzow MR; Tefferi A; Hoagland HC; Pruthi RK; Kaufmann SH
Mayo Clin Proc; 2002 Aug; 77(8):760-2. PubMed ID: 12173711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
